• Ticker

DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$13.61 -$0.01 (-0.07%)

REAL-TIME: Last trade at

Human Genome Sciences

NASDAQ:HGSI

HGSI vs. S&P 500
$13.61 -$0.01 (-0.07%)
Today's Open $13.45
Previous Close $13.62
Daily Range $13.45 - $13.77
52-Week Range $6.51 - $27.46
Market Cap $2.7B
P/E Ratio -7.78
Dividend (Yield) $0.00 (0.0%)
Volume 2,868,244
Average Daily Volume 9,263,632
Current FY EPS -$1.53

Sector

Healthcare

Industry

Biotechnology

Description

The drug development company with three products advancing into late-stage clinical development: Albuferon(r) for chronic hepatitis C, LymphoStat-B(r) for systemic lupus erythematosus, and ABthraxtm for anthrax disease.

News & Commentary

HGSI's Top Competitors

HGSI

$13.61 (-0.07%)

Current stock: HGSI
AMGN

$69.05 (-0.07%)

Current stock: AMGN
GILD

$50.49 (-0.26%)

Current stock: GILD
BIIB

$131.56 (-0.07%)

Current stock: BIIB